Glenmark Pharmaceuticals Ltd (GLENMARK)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 2115.70
% Change: 2.92% (Prev Close: 2055.70)

Volume: 12,69,358
% Change: 50.60% (Prev Volume: 8,42,874)

Delivery: 4,77,073
Delivery % : 37.58
% Change: 22.33% (Prev Delivery: 3,89,989)

Turnover: 26,679 Lacs
% Change: 53.89% (Prev Turnover: 17,336)

πŸ’Ή EOD Valuation

P/E Ratio: 79.21
P/B Ratio: 6.75
Market Cap: 59705 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: GLENMARK
Market Cap: 54293 Rs. Cr.
Face Value: 1.00 Rs.

52 Week High: 2286.15
52 Week Low: 1274.70

All-Time High: 2286.15 Rs.
All-Time Low: 109.25 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
-2.35% | 26.05% | 42.72% | 18.85% | 75.40%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 46.65%

Change (3Y | 1Y): 0.00% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 20.62%

Change (3Y | 1Y): -3.61% | -2.53%

DII Holding

DII Holding: 17.64%

Change (3Y | 1Y): 7.14% | 3.04%

Public Holding: 15.05%

🏦 Financial Strength

Debt to Equity: 0.28
Debt: 2472.67 Rs. Cr.

Book Value: 313.60 Rs.
Current Ratio: 1.56
Interest Coverage: 8.66
Free Cash Flow: -1574.75 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 10.99%

Sales Growth Qtr (YOY | QoQ):
0.62% | 0.25%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
4.60% | 2.68% | 10.99%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: 158.73%

Profit Growth Qtr (YOY | QoQ):
-23.49% | 972.37%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
11.77% | 6.25% | 158.73%

EPS Rs.

EPS (TTM): 26.71 Rs.

EPS Qtr (Last Year | Latest):
12.06 Rs. | 1.66 Rs.

EPS Annual (Last Annual | Annual March):
-53.22 Rs. | 37.11 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
11.77% | 6.24%

Net Profit Rs. Cr.

Net Profit (TTM): 753.86 Rs. Cr.

Net Profit (Annual - March): 1047.15 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
340.24| 4.38 | 46.97

EBITDA Rs. Cr.

EBITDA (Quarter): 606.96 Rs. Cr.
EBITDA (Previous Yr Ql): 619.70 Rs. Cr.

EBITDA (Annual - March): 2465.11 Rs. Cr.
EBITDA (Previous Annual): 2033.80 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
5.81% | -0.38%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 17.57%

OPM Qtr (Previous | Current):
17.23% | 17.78%

OPM Annual (5 Yrs | Last Yr | March):
16.00% | 10.12% | 17.65%

Return on Equity %

ROE: 15.79%

ROE (5 Yrs | 3 Yrs | Last Yr):
-1.40% | -9.94% | -51.65%

Return on Capital Employed %

ROCE: 19.40%

ROCE (5 Yrs | 3 Yrs | Last Yr):
14.38% | 13.81% | 12.34%

Return on Assets %

ROA (TTM): 8.67%

ROA (5 Yrs | 3 Yrs | Last Yr):
-0.07% | -4.56% | -26.12%

PEG Ratio: 6.52
Dividend Yield: 0.13%

PE 3 Yrs: 27.73
PE 5 Yrs: 15.57

Dividend Yield: 0.13%

πŸ‘₯ Company

Glenmark Pharmaceuticals Ltd

GLENMARK

Promoter Holding: %